| Amelia Fonseca Escudero, | |
|
268 Stillwater Ave, Bangor, ME 04401-3945 | |
| (207) 973-6100 | |
| Not Available |
| Full Name | Amelia Fonseca Escudero |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 23 Years |
| Location | 268 Stillwater Ave, Bangor, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942422399 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 225623 (Massachusetts) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD19646 (Maine) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| State Of Maine | 7517875131 | 12 |
News Archive
AnyPresence, the leading enterprise backend-as-a-service platform, today announced that Miami Children's Hospital has implemented the AnyPresence solution for mobile app development, including unique new capabilities in their Fit4KidsCare app.
The Institute for Health Technology Studies has awarded a grant of $240,000 to an international consortium of researchers, for a study that will assess the effects of hip replacement therapy on the employment and retirement decisions of older adults. Led by researchers at the Universit- Bocconi (Milan), the consortium also includes investigators at the University of York (York, UK), and the Johns Hopkins University School of Public Health (Baltimore).
Circadian Age, Inc. – ‘Working Nights' – a company dedicated to helping shift workers and their families adjust to their unique lifestyles, is concerned with making sure that any health care reform will benefit the 25 million Americans working shifts. These workers represent 10% of the insured population, but incur 17% of the health care costs.
With the continued aging of the population and the growing epidemic of Alzheimer's, early detection of the disease is crucial for risk assessment, testing new therapies, and eventual early intervention with better drugs, once they are developed. Four studies reported today at the Alzheimer's Association's 2008 International Conference on Alzheimer's Disease (ICAD 2008) in Chicago bring us closer to that goal of early detection by describing advances in biomarkers.
Top-line data from the 270-patient global Phase 2/3 COVID-19 study expected Q1/2021. Top-line data from the 40-patient U.S. Phase 2 study of opaganib in severe COVID-19 expected in the coming days; this non-powered study was designed to evaluate safety and potential identification of preliminary efficacy signals in support of the global Phase 2/3 study of opaganib.
› Verified 5 days ago
| Entity Name | Acadia Hospital Corp. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215940523 PECOS PAC ID: 7719878495 Enrollment ID: O20040323000136 |
News Archive
AnyPresence, the leading enterprise backend-as-a-service platform, today announced that Miami Children's Hospital has implemented the AnyPresence solution for mobile app development, including unique new capabilities in their Fit4KidsCare app.
The Institute for Health Technology Studies has awarded a grant of $240,000 to an international consortium of researchers, for a study that will assess the effects of hip replacement therapy on the employment and retirement decisions of older adults. Led by researchers at the Universit- Bocconi (Milan), the consortium also includes investigators at the University of York (York, UK), and the Johns Hopkins University School of Public Health (Baltimore).
Circadian Age, Inc. – ‘Working Nights' – a company dedicated to helping shift workers and their families adjust to their unique lifestyles, is concerned with making sure that any health care reform will benefit the 25 million Americans working shifts. These workers represent 10% of the insured population, but incur 17% of the health care costs.
With the continued aging of the population and the growing epidemic of Alzheimer's, early detection of the disease is crucial for risk assessment, testing new therapies, and eventual early intervention with better drugs, once they are developed. Four studies reported today at the Alzheimer's Association's 2008 International Conference on Alzheimer's Disease (ICAD 2008) in Chicago bring us closer to that goal of early detection by describing advances in biomarkers.
Top-line data from the 270-patient global Phase 2/3 COVID-19 study expected Q1/2021. Top-line data from the 40-patient U.S. Phase 2 study of opaganib in severe COVID-19 expected in the coming days; this non-powered study was designed to evaluate safety and potential identification of preliminary efficacy signals in support of the global Phase 2/3 study of opaganib.
› Verified 5 days ago
| Entity Name | State Of Maine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699776146 PECOS PAC ID: 7517875131 Enrollment ID: O20040610001611 |
News Archive
AnyPresence, the leading enterprise backend-as-a-service platform, today announced that Miami Children's Hospital has implemented the AnyPresence solution for mobile app development, including unique new capabilities in their Fit4KidsCare app.
The Institute for Health Technology Studies has awarded a grant of $240,000 to an international consortium of researchers, for a study that will assess the effects of hip replacement therapy on the employment and retirement decisions of older adults. Led by researchers at the Universit- Bocconi (Milan), the consortium also includes investigators at the University of York (York, UK), and the Johns Hopkins University School of Public Health (Baltimore).
Circadian Age, Inc. – ‘Working Nights' – a company dedicated to helping shift workers and their families adjust to their unique lifestyles, is concerned with making sure that any health care reform will benefit the 25 million Americans working shifts. These workers represent 10% of the insured population, but incur 17% of the health care costs.
With the continued aging of the population and the growing epidemic of Alzheimer's, early detection of the disease is crucial for risk assessment, testing new therapies, and eventual early intervention with better drugs, once they are developed. Four studies reported today at the Alzheimer's Association's 2008 International Conference on Alzheimer's Disease (ICAD 2008) in Chicago bring us closer to that goal of early detection by describing advances in biomarkers.
Top-line data from the 270-patient global Phase 2/3 COVID-19 study expected Q1/2021. Top-line data from the 40-patient U.S. Phase 2 study of opaganib in severe COVID-19 expected in the coming days; this non-powered study was designed to evaluate safety and potential identification of preliminary efficacy signals in support of the global Phase 2/3 study of opaganib.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amelia Fonseca Escudero, 268 Stillwater Ave, Bangor, ME 04401-3945 Ph: (207) 973-6100 | Amelia Fonseca Escudero, 268 Stillwater Ave, Bangor, ME 04401-3945 Ph: (207) 973-6100 |
News Archive
AnyPresence, the leading enterprise backend-as-a-service platform, today announced that Miami Children's Hospital has implemented the AnyPresence solution for mobile app development, including unique new capabilities in their Fit4KidsCare app.
The Institute for Health Technology Studies has awarded a grant of $240,000 to an international consortium of researchers, for a study that will assess the effects of hip replacement therapy on the employment and retirement decisions of older adults. Led by researchers at the Universit- Bocconi (Milan), the consortium also includes investigators at the University of York (York, UK), and the Johns Hopkins University School of Public Health (Baltimore).
Circadian Age, Inc. – ‘Working Nights' – a company dedicated to helping shift workers and their families adjust to their unique lifestyles, is concerned with making sure that any health care reform will benefit the 25 million Americans working shifts. These workers represent 10% of the insured population, but incur 17% of the health care costs.
With the continued aging of the population and the growing epidemic of Alzheimer's, early detection of the disease is crucial for risk assessment, testing new therapies, and eventual early intervention with better drugs, once they are developed. Four studies reported today at the Alzheimer's Association's 2008 International Conference on Alzheimer's Disease (ICAD 2008) in Chicago bring us closer to that goal of early detection by describing advances in biomarkers.
Top-line data from the 270-patient global Phase 2/3 COVID-19 study expected Q1/2021. Top-line data from the 40-patient U.S. Phase 2 study of opaganib in severe COVID-19 expected in the coming days; this non-powered study was designed to evaluate safety and potential identification of preliminary efficacy signals in support of the global Phase 2/3 study of opaganib.
› Verified 5 days ago
Judy A Burk, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 656 State St, Dorothea Dix Psychiatric Center, Bangor, ME 04401 Phone: 207-941-4263 Fax: 207-941-4151 | |
Monir Moftakhari Musavi, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 268 Stillwater Avenue, Acadia Hospital Corp, Bangor, ME 04401 Phone: 207-973-6100 Fax: 207-973-6109 | |
Thomas N Rusk, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1012 Union St, Bangor, ME 04401 Phone: 207-945-5247 Fax: 207-990-1248 | |
Edward David, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 498 Essex St, Suite 105, Bangor, ME 04401 Phone: 207-947-0558 Fax: 207-947-0344 | |
Dr. Clifford M Singer, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 268 Stillwater Ave, Bangor, ME 04401 Phone: 207-973-6100 | |
Mrs. Sally Rose Weiss, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 700 Mt Hope Ave, Suite 600, Bangor, ME 04401 Phone: 207-947-2591 Fax: 207-947-2591 | |
Mirna Hajjar, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 498 Essex St, Suite 105, Bangor, ME 04401 Phone: 207-947-0558 |